Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00006328 · ClinicalTrials.gov registry record
Angiotensin-Converting Enzyme Gene Polymorphism and the Risk of Chronic Allograft Nephropathy
A clinical trial, sponsored by National Center for Research Resources (NCRR).
- Completed
- Registry status
NCT00006328 is a clinical trial that has completed, run by National Center for Research Resources (NCRR).
The verdict
NCT00006328 has completed, sponsored by National Center for Research Resources (NCRR).
- COMPLETED
- Registry status
Study Summary
This study is intended to help doctors learn about the relationships between specific genetic makeup (gene markers) and the development of chronic rejection. This study is being done to see if there is a relationship between genetic patterns and the development of Chronic Allograft Nephropathy (CAN). Medical scientists also hope to learn more about how genetic differences between people determine their response to a drug or a disease by storing a small blood sample in a special "bank". This sample may be tested at some point in the future in an attempt to better understand the factors that may influence rejection, transplantation outcomes and transplant success rates.
Trial Details
| Field | Value |
|---|
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00006328
The ClinicalTrials.gov registry entry for NCT00006328 describes a study currently listed as completed, categorized as an unspecified phase. An enrollment target was not published in the registry record, which is common for early-stage or observational entries. The listed sponsor is National Center for Research Resources (NCRR), which has 94 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 0 interventions.
NCT00006328 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00006328 about?
NCT00006328 is a clinical study titled "Angiotensin-Converting Enzyme Gene Polymorphism and the Risk of Chronic Allograft Nephropathy". This study is intended to help doctors learn about the relationships between specific genetic makeup (gene markers) and the development of chronic rejection. This study is being done to see if there is a relationship between genetic patterns and the development of Chronic Allograft Nephropathy (CAN)...
What is the current status of trial NCT00006328?
This trial is currently completed.
Who is sponsoring clinical trial NCT00006328?
This trial is sponsored by National Center for Research Resources (NCRR), which has 94 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.